Seller record · Telehealth service

Peptivo

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the product pages, the terms or the shipping policy. 1 more criterion also fails; see the table below.

At a glance

PeptivoTelehealth service

6/8criteria passed

Price: Compounded semaglutide $179 a month, offered against an original price of $349; a promotional page prints from $99 a month, with no later price printed
Sells: compounded semaglutide, compounded tirzepatide, Ozempic, and 4 more
FDA letters: None on file

Visit Peptivo See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service with no membership fee selling compounded semaglutide and tirzepatide injections with B12, brand-name Ozempic and Zepbound, and compounded sermorelin and NAD+ nasal sprays and creams, prescribed by independent licensed providers, with Strive Pharmacy named for its GLP-1 injection bundles.

Operating entity No legal entity name appears in the footer, the terms or the privacy policy, which name the company only as Peptivo.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Peptivo's website; Peptivo's sermorelin page
S2	Prescription gating	PASS	Peptivo's GLP-1 page; Peptivo's sermorelin page; Peptivo's NAD+ spray page
S3	Pharmacy identification	PASS	Peptivo's website; Peptivo's GLP-1 page
S4	Compounding disclosure	PASS	Peptivo's website; Peptivo's terms and conditions; Peptivo's sermorelin page
S5	Analytical documentation	FAIL	Peptivo's GLP-1 page; Peptivo's terms and conditions; Peptivo's shipping policy
S6	Business address	FAIL	Peptivo's website; Peptivo's terms and conditions; Peptivo's privacy policy
S7	Price disclosure	PASS	Peptivo's terms and conditions; Peptivo's GLP-1 page; Peptivo's sermorelin page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery prescription is written by an independent, licensed provider after an online evaluation, and a provider licensed in the patient's state reviews each intake and declines treatment that is not right.Source: Peptivo's website; Peptivo's sermorelin page.

S2PASSThe steps list a short quiz reviewed by the medical team first, the sermorelin page says the patient is charged only if a provider prescribes, and the NAD+ page promises a full refund if the prescription is not approved.Source: Peptivo's GLP-1 page; Peptivo's sermorelin page; Peptivo's NAD+ spray page.

S3PASSThe GLP-1 product page names Strive Pharmacy for its semaglutide and tirzepatide injection bundles. The current home page does not name the filling pharmacies for its other treatment formats.Source: Peptivo's website; Peptivo's GLP-1 page.

S4PASSThe home page and sermorelin product page state that compounded medications are not approved by the FDA, and the terms separate the compounded semaglutide and tirzepatide packages from the brand-name Ozempic and Zepbound packages.Source: Peptivo's website; Peptivo's terms and conditions; Peptivo's sermorelin page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the terms or the shipping policy.Source: Peptivo's GLP-1 page; Peptivo's terms and conditions; Peptivo's shipping policy.

S6FAILNo postal address for the company is printed. The current home page, terms and privacy policy give no company street address.Source: Peptivo's website; Peptivo's terms and conditions; Peptivo's privacy policy.

S7PASSThe terms price compounded semaglutide at $179 for the first month, against an original price of $349, and $179 a month after, and compounded tirzepatide at $279 for the first month, against an original $449, and $279 after. Ozempic costs $1,299 and Zepbound $1,399 a month, and sermorelin and NAD+ cost $99 for the first month, against an original $199, and $199 after. A promotional weight loss page instead prints semaglutide from $99 a month and tirzepatide from $219 a month, with no later price printed. Each package includes the visit, the medication and shipping.Source: Peptivo's terms and conditions; Peptivo's GLP-1 page; Peptivo's sermorelin page.

S8PASSNo FDA warning letter names Peptivo, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Ozempic, Zepbound, sermorelin nasal spray, NAD+ nasal spray, NAD+ cream.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+

Visit Peptivo

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.